Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of Malnutrition

Inclusion Criteria: * Type 2 diabetes on treatment with one or more oral antidiabetics/insulin and constant dose for at least 2 months * Has HbA1c \< 9.0% based on recent (30 days prior to Baseline visit) laboratory value or analysis of blood sample obtained at Baseline Visit * Adult population with age ≥30 years * Willing to follow the protocol as described * Voluntarily signed and dated an informed consent form (ICF), approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to any participation in the study to allow their data to be collected * Subject is under the care of a health care professional for malnutrition, or is at risk for malnutrition (MUST≥1), and has recently (within the last 7 days prior to participating in this study) been prescribed study oral nutritional supplement (2 servings/day) by their health care professional Exclusion Criteria: * History of T2D longer than 30 years * History of diabetic ketoacidosis and or hyperosmolar hyperglycemic state (HHS) * If on thyroid medication or hormone replacement therapy, has not been on a constant dosage for at least 2 months prior to Baseline Visit * History of metabolic/endocrine (other than diabetes), hepatic (AST/ALT 3 times the upper normal limit), or significant renal disease (GFR \< 60 ml/min/1.73m2) * History of heart failure (\> class II) * Follows a non-typical eating pattern, such as very low carbohydrate diet (e.g., Atkins diet, ketogenic diet, high protein diet), stric…